Wearable Injector & Cartridge QC
AI-powered glass cartridge inspection and drug delivery device assembly verification. Detect delamination, fill defects, and device integration failures before they reach patients.
The Wearable Injector Challenge
Wearable drug delivery devices (auto-injectors, pen devices, wearable pumps) with integrated pharmaceutical glass cartridges face extreme quality and regulatory demands. Your manufacturing lines encounter:
Cartridge Glass Defects
- Delamination & striations: Invisible to 2D inspection; cause drug precipitation, loss of efficacy, patient safety risk (USP <1>, Ph. Eur.)
- Surface scratches & particulates: Glass fragments in drug; potential for patient harm, regulatory action, recall
- Fill volume variability: Incorrect cartridge fill = wrong dosing, clinical failures, liability
- Sealant integrity: Plunger seal defects in siliconized cartridges; drug leakage, contamination, sterility failure
- Chemical compatibility: Glass type & coating must match drug formulation (pH, osmolarity, protein interactions)
Device Assembly Integration
- Cartridge seating: Misaligned cartridge in needle hub assembly = mechanical failure, injection malfunction
- 100% inspection bottleneck: Manual visual QC of cartridge + device integration is labour-intensive; AQL inspection misses defects
- Regulatory documentation: FDA/EMA requires serialized unit traceability, defect logs, and integration verification per device
- SOP variance: Assembly instructions (cartridge loading, alignment torque, sealant verification) drift across production sites
- Supply chain risk: Cartridge suppliers ship without image-based proof-of-quality; integration failures discovered too late
PIQAPART: Cartridge Glass + Device Integration Inspection
Logirobotix AI delivers 100% cartridge and wearable injector QC—detecting delamination, fill defects, and assembly failures before the device reaches patients.
Cartridge Glass Inspection
Multi-spectral imaging detects defects invisible to 2D human inspection:
- Delamination & striations: 3D/volumetric analysis of glass structure; detects subsurface flaws <50 µm
- Surface scratches & particulates: Automated detection + image-based traceability (which cartridge batch, which production line)
- Fill volume verification: Optical measurement of drug level within ±5% accuracy; alerts on under/overfill
- Sealant integrity: Plunger seal alignment, closure plug seating, siliconization uniformity check
- Glass type verification: Optical signature confirms Type I borosilicate (vs. contaminated Type III); chemical compatibility validation
Device Assembly Verification
Validates cartridge-to-device integration and mechanical functionality:
- Cartridge seating: Confirms correct positioning in needle hub (axial/radial alignment, torque sequence)
- Needle sterility: Detects shield removal, protective cap integrity
- Device mechanics: Trigger assembly, spring tension verification, dose counter alignment
- Automated SOPs: Step-by-step assembly instructions auto-generated from production video; multilingual (30+ languages)
- Regulatory traceability: Serialized inspection records (image + metadata) linked to batch, lot, and device serial number
Technical Capabilities
Cartridge Glass Inspection
| Defect Type | Detection Method | Regulatory Standard |
|---|---|---|
| Delamination & Striations | 3D volumetric imaging; sub-surface detection <50 µm | USP <1> (Injections); Ph. Eur. 3.2.1 (Glass containers) |
| Surface Scratches, Cracks | Multi-angle polarized lighting; 20 µm resolution | USP <921> (Surface Inspections) |
| Particulates & Glass Fragments | Dark-field imaging; AI particle classification (size, material) | Ph. Eur. 2.9.19 (Particulate matter in injectables) |
| Fill Volume | Optical meniscus measurement; ±2% accuracy | USP <905> (Uniformity of dosage units) |
| Sealant Integrity (Plunger) | Dimensional analysis; silicone coating uniformity check | ISO 6601-1 (Syringes for medical use) |
| Glass Type Verification | Optical signature + refractive index analysis | Ph. Eur. 3.2.1 (Type I borosilicate confirmation) |
Device Assembly Verification
| Assembly Checkpoint | AI Verification | Output / Action |
|---|---|---|
| Cartridge Seating | Position analysis (axial/radial offset <0.5 mm); torque inference from mechanical fit | Automatic pass/fail; rework queue if misaligned |
| Needle Hub Integrity | Sterile field presence; protective cap status; needle visibility check | Critical reject if sterility compromised |
| Device Mechanics | Trigger alignment, spring assembly, dose counter position | Functional readiness score; test cycle recommendation if uncertain |
| Label & Serialization | Label presence, barcode/QR readability, expiry date legibility | Barcode link to device record; traceability confirmed |
Documentation & Traceability
| Deliverable | Format & Languages | Compliance Scope |
|---|---|---|
| Assembly SOPs | PDF, HTML, QR codes (production floor display); 30+ languages auto-generated | ISO 13485 (Process documentation); IEC 62079 (User instructions) |
| Inspection Reports | PDF (human-readable), XML (machine-readable), CSV (analytics) | FDA Annex 1 (Aseptic processing); EU MDR Technical Documentation |
| Cartridge Traceability | Image archive (1 photo per cartridge) + metadata (supplier, batch, defect classification) | USP <1> (Lineage tracking); Drug-device regulatory dossier |
| Device History Record (DHR) | Serial-linked JSON + PDF; includes inspection images, assembly video frames, lot numbers | 21 CFR Part 11 (Electronic records); GAMP 5 validation-ready |
Wearable Injector Use Cases
High-Volume Cartridge + Device Assembly (e.g., Novo Nordisk FlexPen, Eli Lilly KwikPen)
Challenge: Millions of units/year; cartridge delamination = drug degradation = efficacy failure. Manual inspection at AQL 0.65 misses delamination (subsurface defect invisible to 2D). Each defect found post-market = recall, liability, patient harm.
Solution: 100% cartridge glass inspection via AI volumetric imaging; delamination detection <50 µm. Device assembly verification ensures proper cartridge seating in needle hub. Serialized inspection images linked to cartridge batch & device serial. Automated FDA/EMA submission package (inspection records, defect logs, traceability) generated daily.
Impact: Zero delamination-related field returns; audit-ready documentation; 3-month payback via scrap/rework reduction (currently 8-12% of cartridges rejected at customer sites).
Cartridge Glass + Adhesive Patch Assembly (e.g., Amgen, Biogen programs)
Challenge: Cartridge fill is biologics (antibodies, mAbs, biosimilars)—extremely sensitive to glass type, pH, and particulates. Patch adhesive must not compress cartridge or cause seal degradation. Regulatory path is complex (drug-device combination product).
Solution: AI verifies cartridge glass type (optical signature confirms Type I borosilicate), detects fill-level variation ±2%, and measures sealant integrity. Adhesive patch positioning validated; force imaging confirms cartridge is not compressed. Generates integrated drug-device technical documentation (dual-approval pathway).
Impact: Reduced development risk; faster regulatory submissions; zero patient safety incidents from glass-drug incompatibility.
Pre-loaded Cartridge Cassettes for Wearable Insulin/Infusion Pumps
Challenge: Cartridge magazine assembly requires precise alignment of multiple cartridges in a cassette frame. Misalignment = pump failure, no drug delivery, patient hyperglycemia. Defects are mechanical (not visible on cartridge surface) and only discovered during pump testing.
Solution: AI inspects cartridge positioning within cassette (±0.2 mm tolerance); detects cracks in cartridge caused by cassette assembly forces. Magazine structural integrity verified. Inspection video converted to training SOPs for technicians.
Impact: 40% reduction in pump field failures; faster cassette assembly throughput; reduced return rates.
Supply Chain Verification (Glass Cartridge Pre-Qualification)
Challenge: Cartridge suppliers (e.g., Gerresheimer, Nippon, Schott) deliver to device assemblers without image-based proof-of-quality. Integration failures discovered too late. Supplier disputes on defect liability are common.
Solution: Implement AI inspection at device assembly line (or supplier site). Every received cartridge batch inspected and image-logged. Supplier receives feedback report (defect photos, statistics). If defect rate exceeds SLA, cartridge lot is rejected upstream. Reduces supplier surprises; establishes objective quality baseline.
Impact: Elimination of supplier disputes; 50% reduction in incoming inspection overhead; improved supplier accountability & quality culture.
Integration & Deployment for Pharma Glass Assembly
Specialized Imaging for Glass
- Multi-spectral & polarized lighting (delamination detection)
- 3D/volumetric imaging for subsurface defect analysis
- Customizable camera mounting (pre-assembly, post-filling, post-device closure)
- Temperature-controlled imaging (glass refractive index varies with temp)
- High-speed inspection (sub-second per cartridge; supports 100+ units/min)
Pharma-Grade Software Integration
- MES connectivity (SAP, Infor, Apriso) with serialized lot tracking
- FDA 21 CFR Part 11 compliance (audit trails, electronic signatures, data integrity)
- Real-time alerts & defect routing (QA hold, rework queue, scrap bin)
- On-premise data retention (no cloud dependency for regulated environments)
- Validation-ready (GAMP 5 framework for regulated industries)
Typical Deployment Timeline
Week 1-2: Assessment
Site visit, line walkthrough, defect profiling, documentation audit. Define inspection points and SOP templates.
Week 3-4: Setup & Training
Hardware install, AI model training (50-100 good/defect samples), personnel training, pilot production runs.
Week 5+: Production & Optimization
Live inspection, documentation auto-generation, continuous model refinement. ROI typically realized within 3 months.
Return on Investment for Wearable Injector QC
For high-volume cartridge + device assembly (>1M units/year):
Direct Scrap & Rework Savings
Cartridge defect detection: Current AQL 0.65 inspection misses 8-12% delamination. AI catches these pre-assembly = €150K-400K annual savings (scrap cost: €15-30/cartridge)
Device assembly rework: Misaligned cartridge-in-device defects reduced 60% = €80K-150K savings
Documentation automation: SOPs, traceability logs, regulatory reports = €50K-100K/year labour reduction
Indirect Benefits & Risk Mitigation
Recall avoidance: Early detection prevents field failures (recall cost: €2M-10M+ per incident)
Regulatory readiness: Audit-ready traceability; FDA/EMA inspection confidence (zero findings)
Supply chain efficiency: Supplier accountability; faster cartridge qualification; zero dispute-related delays
Patient safety: Zero field returns due to delamination or integration failures
Typical payback period: 3-6 months. Investment (€150K-250K hardware + software) ÷ annual scrap savings (€250K-600K) = 3-9 months. Risk mitigation (recall avoidance) can reduce payback to <3 months.
Ready to Transform Wearable QC?
Talk to our technical team about your assembly line, defect challenges, and compliance needs.